Source: European Journal of Medicinal Chemistry. Unidades: FCFRP, FMRP
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARTMANN, Ana Paula et al. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity. European Journal of Medicinal Chemistry, v. 140, p. 187-199, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2017.08.064. Acesso em: 31 out. 2024.APA
Hartmann, A. P., Carvalho, M. R. de, Bernardes, L. S. C., Moraes, M. H. de, Melo, E. B. de, Lopes, C. D., et al. (2017). Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity. European Journal of Medicinal Chemistry, 140, 187-199. doi:10.1016/j.ejmech.2017.08.064NLM
Hartmann AP, Carvalho MR de, Bernardes LSC, Moraes MH de, Melo EB de, Lopes CD, Steindel M, Silva JS da, Carvalho I. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity [Internet]. European Journal of Medicinal Chemistry. 2017 ; 140 187-199.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejmech.2017.08.064Vancouver
Hartmann AP, Carvalho MR de, Bernardes LSC, Moraes MH de, Melo EB de, Lopes CD, Steindel M, Silva JS da, Carvalho I. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity [Internet]. European Journal of Medicinal Chemistry. 2017 ; 140 187-199.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejmech.2017.08.064
